PNPLA2 and cardiac hypertrophy: Adipocyte ATGL deletion also attenuates the development of exercise-induced physiological cardiac hypertrophy [135], as well as TAC-induced cardiac hypertrophy and associated left ventricular phosphatidylethanolamine (PE) elevation [136].